126 related articles for article (PubMed ID: 36326467)
1. Systemic computational investigation to identify potential inhibitors against cancer by targeting P21-activated kinase 4 and D(CGATCG).
Ahmed AH; Jassim TS; Ali RW; Hameed AR; Alfalki AM
J Biomol Struct Dyn; 2023 Nov; 41(19):9356-9365. PubMed ID: 36326467
[TBL] [Abstract][Full Text] [Related]
2. Unveiling MurE ligase potential inhibitors for treating multi-drug resistant
Altharawi A; Alqahatani SM; Alanazi MM; Tahir Ul Qamar M
J Biomol Struct Dyn; 2024 Mar; 42(5):2358-2368. PubMed ID: 37099644
[No Abstract] [Full Text] [Related]
3. Structural Dynamics of P-Rex1 Complexed with Natural Leads Establishes the Protein as an Attractive Target for Therapeutics to Suppress Cancer Metastasis.
Hameed AR; Ali SF; Alsallameh SMS; Muhseen ZT; Almansour NM; ALSuhaymi N; Alsugoor MH; Allemailem KS
Biomed Res Int; 2023; 2023():3882081. PubMed ID: 38098889
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition of cathepsin C (CatC) as a potential approach for cancer therapeutics.
Abideen SA; Khan M; Al-Harbi AI; Ahmad S
J Biomol Struct Dyn; 2023; 41(18):8682-8689. PubMed ID: 36264138
[TBL] [Abstract][Full Text] [Related]
5. Cheminformatics and biomolecular dynamics studies towards the discovery of anti-staphylococcal nuclease domain-containing 1 (SND1) inhibitors to treat metastatic breast cancer.
Makki Almansour N
Saudi Pharm J; 2023 Oct; 31(10):101751. PubMed ID: 37693734
[TBL] [Abstract][Full Text] [Related]
6. Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach to reveal potent PPAR- γ agonist against cancer.
Lokhande KB; Ballav S; Yadav RS; Swamy KV; Basu S
J Biomol Struct Dyn; 2022 Feb; 40(3):971-981. PubMed ID: 32954977
[TBL] [Abstract][Full Text] [Related]
7. Identification of potential drug molecules against fibroblast growth factor receptor 3 (FGFR3) by multi-stage computational-biophysics correlate.
Ahmad S; Almanaa TN; Khan S; Aljahdali SM; Waheed Y; Aljasir MA; Al-Megrin WAI; Aziz A; Ateeq M; Amin F; Khattak SU; Sanami S
J Biomol Struct Dyn; 2023 Dec; ():1-9. PubMed ID: 38064307
[TBL] [Abstract][Full Text] [Related]
8. A hierarchical approach towards identification of novel inhibitors against L, D-transpeptidase YcbB as an anti-bacterial therapeutic target.
Alawam AS; M Alneghery L; Alwethaynani MS; Alamri MA
J Biomol Struct Dyn; 2024 Feb; ():1-11. PubMed ID: 38411016
[TBL] [Abstract][Full Text] [Related]
9. Screening of potential drug for Alzheimer's disease: a computational study with GSK-3 β inhibition through virtual screening, docking, and molecular dynamics simulation.
Elangovan ND; Dhanabalan AK; Gunasekaran K; Kandimalla R; Sankarganesh D
J Biomol Struct Dyn; 2021 Nov; 39(18):7065-7079. PubMed ID: 32779973
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
11. Structure-based virtual screening, molecular dynamics simulation and MM-PBSA toward identifying the inhibitors for two-component regulatory system protein NarL of
Kumar N; Srivastava R; Prakash A; Lynn AM
J Biomol Struct Dyn; 2020 Jul; 38(11):3396-3410. PubMed ID: 31422761
[TBL] [Abstract][Full Text] [Related]
12. A computational approach to explore and identify potential herbal inhibitors for the p21-activated kinase 1 (PAK1).
Shahinozzaman M; Ishii T; Ahmed S; Halim MA; Tawata S
J Biomol Struct Dyn; 2020 Aug; 38(12):3514-3526. PubMed ID: 31448698
[TBL] [Abstract][Full Text] [Related]
13. Identification of potent EGFR-TKD inhibitors from NPACT database through combined computational approaches.
Mir SA; Muhammad A; Padhiary A; Ekka NJ; Baitharu I; Naik PK; Nayak B
J Biomol Struct Dyn; 2023; 41(21):12063-12076. PubMed ID: 36695102
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor 2 is a druggable target against glioblastoma: A computational investigation.
Siddique R; Abideen SA; Nabi G; Awan FM; Noor Khan S; Ullah F; Khan S; Xue M
Front Chem; 2022; 10():1071929. PubMed ID: 36505741
[TBL] [Abstract][Full Text] [Related]
15. A cheminformatics-biophysics correlate to identify promising lead molecules against matrix metalloproteinase-2 (MMP-2) enzyme: A promising anti-cancer target.
Alrumaihi F
Saudi Pharm J; 2023 Jul; 31(7):1244-1253. PubMed ID: 37284415
[TBL] [Abstract][Full Text] [Related]
16. An integrated computational approach towards novel drugs discovery against polyketide synthase 13 thioesterase domain of Mycobacterium tuberculosis.
Altharawi A; Alossaimi MA; Alanazi MM; Alqahatani SM; Tahir Ul Qamar M
Sci Rep; 2023 Apr; 13(1):7014. PubMed ID: 37117557
[TBL] [Abstract][Full Text] [Related]
17. Potential target identification for breast cancer and screening of small molecule inhibitors: A bioinformatics approach.
Agarwal S; Kashaw SK
J Biomol Struct Dyn; 2021 Apr; 39(6):1975-1989. PubMed ID: 32186248
[TBL] [Abstract][Full Text] [Related]
18. In silico identification of potential Hsp90 inhibitors via ensemble docking, DFT and molecular dynamics simulations.
Rezvani S; Ebadi A; Razzaghi-Asl N
J Biomol Struct Dyn; 2022; 40(21):10665-10676. PubMed ID: 34286666
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel chemical scaffolds against kinase domain of cancer causing human epidermal growth factor receptor 2: a systemic chemoinformatic approach.
Alrumaihi F
J Biomol Struct Dyn; 2023 Jul; ():1-11. PubMed ID: 37424103
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
